Global Healthcare Spending And Aging Will Squeeze Hospital Revenues

Published
17 Apr 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$19.00
27.3% overvalued intrinsic discount
16 Aug
US$24.18
Loading
1Y
-33.1%
7D
2.1%

Author's Valuation

US$19.0

27.3% overvalued intrinsic discount

AnalystLowTarget Fair Value

Shared on07 May 25
Fair value Decreased 43%

AnalystLowTarget has increased revenue growth from 3.3% to 3.8% and decreased future PE multiple from 22.0x to 18.4x.

Shared on30 Apr 25
Fair value Increased 0.06%

AnalystLowTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 19%

AnalystLowTarget made no meaningful changes to valuation assumptions.